Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-03-01 @ 12:05 PM
Study NCT ID:
NCT01663766
Status:
TERMINATED
Last Update Posted:
2021-08-19
First Post:
2012-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Milatuzumab for Graft Versus Host Disease
Sponsor:
Organization: